-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: January 2012
ARPA-E Helps Early Stage Companies Commercialize Energy Innovations
Q&A with ARPA-E Deputy Director for Commercialization Cheryl Martin Q: What is the mission of ARPA-E, and how do you work to further that mission? ARPA-E’s mission is to develop advanced energy technologies that can reduce U.S. energy consumption, emissions, and our reliance on foreign energy sources. At the core, we are a technology funding agency, with a focus on next-generation, game-changing energy advances. We award funding for research and development, with the goal of Read More >
Governors Talk Biotech in State of the State Addresses
State legislatures throughout the country are back in session – or soon will be. That means it is time for governors to deliver their annual state of the state addresses. In fact, several have already happened. Just in the last week, Missouri Governor Jay Nixon and West Virginia Governor Earl Ray Tomlin made reference to the biotech industry as an important part of their economic development strategy. As the economy continues to slowly chug upward, Read More >
BIO Applauds U.S.-Japan Action on GE Papaya
The U.S. Department of Agriculture has announced that the Government of Japan approved Hawaii’s Rainbow papaya for commercial shipment to Japan. The Rainbow papaya is genetically engineered to be resistant to the papaya ringspot virus. This announcement marks the beginning of a new chapter for Hawaiian papaya growers. “The market opening in Japan is great news for Hawaii’s papaya producers and even better news for American agricultural exports,” said Michael Scuse, Acting Under Secretary for Read More >
Mass. Governor Patrick Looking Forward to the BIO International Convention
In just six months, Boston will be welcoming more than 15,500 of the world’s leading biotech stakeholders to the biggest industry event of the year – the 2012 BIO International Convention. Both Massachusetts Governor Deval Patrick and Boston Mayor Thomas Menino attended a kickoff breakfast in October where they voiced their industry support: “It’s an honor to have BIO coming back so soon,” said Gov. Patrick. “By drawing the world’s attention once again to our Read More >
Sizing up the NBI in 2011
How did the Nasdaq Biotechnology Index (NBI) perform in 2011 relative to other sectors? Second place. Not so bad considering 2011 was the year of defense in the stock market. Like a page out of a textbook on defensive market plays, utilities edged out ahead with a +15% gain, followed by consumer staples with 11%. The NBI squeezed in between at 12%, just above the overall healthcare sector. Overall, the S&P500 was flat for the Read More >
